Lung neuroendocrine neoplasm
Clinical trials for Lung neuroendocrine neoplasm explained in plain language.
Never miss a new study
Get alerted when new Lung neuroendocrine neoplasm trials appear
Sign up with your email to follow new studies for Lung neuroendocrine neoplasm, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Radioactive drug takes on standard therapy in lung cancer trial
Disease control Recruiting nowThis phase II trial tests whether a radioactive drug called lutetium Lu 177 dotatate works better than the usual drug everolimus for people with advanced bronchial neuroendocrine tumors (a type of lung cancer). The radioactive drug targets a protein on tumor cells and delivers ra…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Radioactive drug takes on standard therapy for rare lung and thymus cancers
Disease control Recruiting nowThis Phase 3 trial tests whether a radioactive drug called 177Lu-edotreotide works better than the standard drug everolimus for people with advanced neuroendocrine tumors of the lung or thymus. About 170 participants will receive either six cycles of the radioactive therapy or da…
Matched conditions: LUNG NEUROENDOCRINE NEOPLASM
Phase 3 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC